Mahoney Michael F Insider Trading Activity

Average Profitability
22.02%
Insider Buys Quantity
4
Insider Buys Sum
$2.77M
Insider Sells Quantity
27
Insider Sells Sum
$256.43M

Insider Activity of Mahoney Michael F

According to the SEC Form 4 filings, Mahoney Michael F, being in a position of

  1. Chairman, President & CEO at Boston Scientific Corporation,
    оver the last 12 months, has bought 0 shares, and sold 818883 shares for $77.92M,
    over all time since 2012-07-31, has bought 33700 shares for $264,966, and sold 5598264 shares for $273.49M.

Biography of Mahoney Michael F

Michael F. Mahoney, 58, is a distinguished leader in the healthcare and medical devices industry. Currently, he serves as the Chairman, President, and CEO of Boston Scientific Corporation, one of the world's top medical device manufacturers. Mahoney has been with Boston Scientific since 2012, where he has played a pivotal role in driving the company's growth and innovation in the medical technology sector. Under his leadership, Boston Scientific has expanded its global footprint and diversified its portfolio, focusing on cardiology, endoscopy, …

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$2,001,000117
Sells
$77,918,823583

Comparison of Insiders on Amount of Buys and Sells

2025-09-05SaleAppLovin Corporation
APP
director
350
0.0001%
$487.97$170,790+0.47%
2025-09-05SaleAres Management Corporation
ARES
Co-Founder & Exec. Chairman
176,784
0.0818%
$177.05$31.3M+0.14%
2025-09-05SaleAvista Corporation
AVA
Vice President
1,367
0.0017%
$36.72$50,196+0.41%
2025-09-05SaleAxsome Therapeutics, Inc.
AXSM
director
9,127
0.0183%
$125.07$1.14M+0.08%
2025-09-05PurchaseBlink Charging Co.
BLNK
Chief Financial Officer
6,000
0.0059%
$1.02$6,144-0.39%
2025-09-05SaleBrixmor Property Group Inc.
BRX
See remarks
25,000
0.0082%
$28.21$705,250-0.04%
2025-09-05PurchaseFirst Busey Corporation
BUSE
President
7,960
$25.44$202,502-2.99%
2025-09-05PurchaseBankwell Financial Group, Inc.
BWFG
director
180
0.0023%
$42.53$7,655+1.29%
2025-09-05SaleCogent Communications Holdings, Inc.
CCOI
VP OF NETWORK STRATEGY
2,400
0.0049%
$36.99$88,776-0.3%
2025-09-05PurchaseThe Cooper Companies, Inc.
COO
President, CooperVision, Inc.
1,450
0.0007%
$69.23$100,384-1.65%
2025-09-05PurchaseThe Cooper Companies, Inc.
COO
President & CEO
10,000
0.005%
$68.39$683,900-0.44%
2025-09-05SaleCenturi Holdings, Inc.
CTRI
10 percent owner
27.36M
28.0208%
$19.60$536.3M+10.15%
2025-09-05SaleCousins Properties Incorporated
CUZ
SVP, Chief Accounting Officer
4,612
0.0027%
$29.30$135,132+0.58%
2025-09-05SaleNoble Corporation Plc
NE
SVP, Operations
35,000
0.0221%
$28.62$1M-0.07%
2025-09-05SaleQCR Holdings, Inc.
QCRH
President & CEO, QCBT
333
0.002%
$80.00$26,640-2.06%
2025-09-05SaleArcus Biosciences, Inc.
RCUS
Chief Accounting Officer
1,579
0.0014%
$11.88$18,758+2.61%
2025-09-05SaleAvidity Biosciences, Inc.
RNA
President and CEO
50,000
0.0385%
$49.95$2.5M+0.82%
2025-09-05SaleRoivant Sciences Ltd.
ROIV
10 percent owner
385,816
0.0567%
$12.96$5M-0.31%
2025-09-05PurchaseSafety Insurance Group, Inc.
SAFT
director
2,000
0.0134%
$72.39$144,780+0.26%
2025-09-05SaleSera Prognostics, Inc.
SERA
director
222
0.0006%
$3.35$744-0.3%
Total: 830324
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD